Risk factors for sessile serrated adenomas

Journal of Clinical Gastroenterology

Volumn 45, Issue 8, 2011, Pages 694-699

  Anderson, Joseph Carl ^a   Rangasamy, Priya ^a   Rustagi, Tarun ^a   Myers, Matthew ^a   Sanders, Melinda ^a   Vaziri, Haleh ^a   Wu, George ^a   Birk, John W ^a   Protiva, Petr ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

colon cancer; diabetes; obesity; serrated adenoma; smoking; tubular adenomas

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CANCER PATIENT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECTUM ADENOMA; RETROSPECTIVE STUDY; RISK FACTOR; SESSILE SERRATED ADENOMA; SEX DIFFERENCE; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOMA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; CONNECTICUT; DIABETES COMPLICATIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 80052021547     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318207f3cf     Document Type: Article

References (62)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genetics. 2006;38:787-793. (Pubitemid 43980599)
3. Kambara T, Simms LA, Whitehall VLJ, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144. (Pubitemid 38961968)
4. Rosenberg DW, Yang S, Pleau DC, et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res. 2007;67:3551-3554. (Pubitemid 46762136)
5. Li D, Jin C, McCulloch C, et al. Association of large serrated polpys with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009;104:695-702.
6. Brenner H, Hoffmeister M, Arndt V, et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: Population-Based Study. J Natl Cancer Inst. 2010;102:89-95.
7. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of Colonoscopy and Death From Colorectal Cancer. Ann Intern Med. 2009;150:1-8.
8. Martinez ME, McPherson RS, Levin B, et al. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 1997;113:423-429. (Pubitemid 27351766)
9. Paskett ED, Reeves KW, Pineau B, et al. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control. 2005;16:1021-1033. (Pubitemid 41355999)
10. Kearney J, Giovannucci E, Rimm EB, et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum. (United States). Cancer Causes Control. 1995; 6:45-56.
11. Morimoto LM, Newcomb PA, Ulrich CM, et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev. 2002;11:1012-1018. (Pubitemid 35192651)
12. Wallace K, Grau MV, Ahnen D, et al. The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum. Cancer Epidemiol Biomarkers Prev. 2009;18:2310-2317.
13. Anderson JC, Attam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol. 2003;98: 2777-2783. (Pubitemid 38020123)
14. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290:2959-2967. (Pubitemid 37505528)
15. Giovannucci E, Rimm EB, Stampfer MJ, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and coloroectal cancer in U.S. men. J Natl Cancer Inst. 1994;86: 183-191. (Pubitemid 24042259)
16. Giovannucci E, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 1994;86: 192-199. (Pubitemid 24042260)
17. Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000;92:1888-1896. (Pubitemid 32036919)
18. Colangelo LA, Gapstur SM, Gann PH, et al. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow up. Cancer. 2004;100:288-293. (Pubitemid 38063636)
19. Paskett ED, Reeves KW, Rohan TE, et al. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst. 2007;99:1729-1735. (Pubitemid 351767214)
20. Rex DK, Johnson DA, Anderson JC, et al. American college of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 104:739-750.
21. Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300:2765-2778.
22. Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134:388-395.
23. Ilyas M, Straub J, Tomlinson IP, et al. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:1986-2002. (Pubitemid 30026220)
24. Sparks R, Bigler J, Sibert JG, et al. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps. Int J Epidemiol. 2004;33:955-961. (Pubitemid 39429987)
25. Weston AP, Campbell DR. Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol. 1995;90: 24-28.
26. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537. (Pubitemid 20172523)
27. Otori K, Oda Y, Sugiyama K, et al. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut. 1997;40:660-663. (Pubitemid 27278336)
28. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816-819. (Pubitemid 23167612)
29. Yang P, Cunningham JM, Halling KC, et al. Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab. 2000;71:639-645. (Pubitemid 32039350)
30. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105:1189-1195.
31. Yu JH, Bigler J, Whitton J, et al. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol. 2006;101:1313-1319. (Pubitemid 43829999)
32. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microstaellite instability in colon tumors. J Natl Cancer Inst. 2000;92: 1831-1836.
33. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst. 2006;98:1731-1738. (Pubitemid 44942711)
34. Anderson JC, Pleau DC, Rajan TV, et al. Increased frequency of serrated aberrant crypt foci among smokers. Am J Gastroenterol. 2010;105:1648-1654.
35. Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc. 1997;46:492-496. (Pubitemid 28018542)
36. Urbanski SJ, Kossakowska AE, Marcon N, et al. Mixed hyperplastic adenomatous polyps: an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol. 1984; 8:551-556. (Pubitemid 14083982)
37. Anderson JC, Pollack BJ. Predicting of hyperplastic histology by endoscopic features. Gastrointest Endosc. 2000;52:149-150. (Pubitemid 30469741)
38. Rashid A, Houlihan PS, Booker S, et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology. 2000;119:323-332. (Pubitemid 30621982)
39. Makinen MJ, George SMC, Jernvall P, et al. Colorectal carcinoma associated with serrated adenoma: prevalence, histologic features, and prognosis. J Pathol. 2001;193:286-294. (Pubitemid 32229858)
40. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol. 2001;193:283-285. (Pubitemid 32229857)
41. Torlakovic E, Skovland E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81. (Pubitemid 36014900)
42. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778-796. (Pubitemid 37047838)
43. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001;93: 1307-1313. (Pubitemid 32910571)
44. O'Brien MJ, Yang S, Clebanoff JL, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and k-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004:28;423-434. (Pubitemid 38436515)
45. Wang L, Cunningham JM, Winters JL, et al. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res. 2003;63:5209-5212. (Pubitemid 37139829)
46. Koinuma K, Shitoh K, Miyakura Y, et al. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas. Int J Cancer. 2004;108: 237-242. (Pubitemid 37541777)
47. Stein B, Anderson JC, Rajapakse R, et al. Body Mass Index as a Predictor of Colorectal Neoplasia in Ethnically Diverse Screening Population. Dig Dis Sci. 2010;55:2945-2952.
48. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma. J Cancer Res. 1989;80:51-58. (Pubitemid 20027198)
49. Wu X, Fan Z, Masui H, et al. Apoptosis induced by an antiepidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest. 1995;95:1897-1905.
50. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 1996;5: 1013-1015. (Pubitemid 26415875)
51. Corpet DE, Jacquinet C, Peiffer G, et al. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer. 1997;27:316-320. (Pubitemid 27161531)
52. Limburg PJ, Vierkant RA, Fredericksen ZS, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a Population-Based, Retrospective Cohort Study. Am J Gastroenterol 2006;101:1872-1879. (Pubitemid 44166600)
53. Attvall S, Fowelin J, Lager I, et al. Smoking induces insulin resistance- potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327-332. (Pubitemid 23114981)
54. Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care. 1996;19:112-118. (Pubitemid 26039130)
55. Targher G, Alberiche M, Zenere MB, et al. Cigarette smoking and insulin resistance in patients with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:3619-3624. (Pubitemid 27509346)
56. Kaklamani VG, Linos A, Kaklamani E, et al. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol. 1999;17:813-817. (Pubitemid 29109310)
57. Borissova AM, Tankova T, Kirilov G, et al. The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. Diabetes Metab. 2004;30:147-152. (Pubitemid 38715170)
58. Anderson JC, Stein B, Kahi CJ, et al. Association of smoking and flat adenomas: Results from an asymptomatic population screened with a high definition colonosocpe. Gastrointest Endosc. 2010;7:1234-1240.
59. Bressler B, Paszat L, Chen Z, et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96-102. (Pubitemid 46108740)
60. Pickhardt PJ, Nugent PA, Choi JR, et al. Flat colorectal lesions in asymptomatic adults: implications for screening with CT virtual colonoscopy. AJR Am J Roentgenol. 2004;183: 1343-1347. (Pubitemid 44210599)
61. Winawer SJ. A quarter century of colorectal cancer screening: progress and prospects. J Clin Oncol. 2001;19(18S): 6s-12s. (Pubitemid 32880072)
62. Rex DK, Lieberman DA. Feasibility of colonoscopy screening: discussion of issues and recommendations regarding implementation. Gastrointest Endosc. 2001;54:662-667.